Literature DB >> 18347982

Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.

Eric R Kallwitz1, Mrudula Kumar, Radhika Aggarwal, Reed Berger, Jennifer Layden-Almer, Neil Gupta, Scott J Cotler.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a growing problem that is associated with the metabolic syndrome. The goal of the present study was to evaluate for ethnic differences in NAFLD and clinical correlates of NAFLD. The study population consisted of 567 patients seen at an urban obesity clinic. Elevated aminotransferase levels were used as a surrogate marker for NAFLD. The prevalence of elevated aminotransferases was highest in Hispanics (39%), followed by Caucasians (28%), and African Americans (12%). In univariate analysis, elevated aminotransferase levels were associated with ethnicity (Hispanic > African American, P < 0.001, and Caucasian > African American P = 0.030), hypertriglyceridemia (P < 0.001), and male gender (P < 0.001). The pattern of results was confirmed in multivariate analysis, except that the differences between Caucasians and African Americans was no longer significant. In conclusion, in an obesity clinic population, elevated aminotransferase levels and hypertriglyceridemia were most common in Hispanics and least common in African Americans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347982     DOI: 10.1007/s10620-008-0234-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Increased fasting triglyceride levels are associated with hepatic insulin resistance in Caucasian but not African-American adolescents.

Authors:  Robert P Hoffman
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

3.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

4.  Abdominal fat distribution and metabolic risk factors: effects of race.

Authors:  J C Lovejoy; J A de la Bretonne; M Klemperer; R Tulley
Journal:  Metabolism       Date:  1996-09       Impact factor: 8.694

5.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

6.  The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

Authors:  Se-Yong Oh; Yong-Kyun Cho; Mun-Su Kang; Tae-Woo Yoo; Jung-Ho Park; Hong-Joo Kim; Dong-Il Park; Chong-Il Sohn; Woo-Kyu Jeon; Byung-Ik Kim; Byung-Ho Son; Jun-Ho Shin
Journal:  Metabolism       Date:  2006-12       Impact factor: 8.694

7.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

8.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

9.  Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.

Authors:  Steven F Solga; Jeanne M Clark; Amir R Alkhuraishi; Michael Torbenson; Alireza Tabesh; Michael Schweitzer; Anna Mae Diehl; Thomas H Magnuson
Journal:  Surg Obes Relat Dis       Date:  2005 Jan-Feb       Impact factor: 4.734

10.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

View more
  9 in total

Review 1.  Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.

Authors:  Christine C Hsu; Erik Ness; Kris V Kowdley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

2.  Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?

Authors:  James H Tabibian; Mariana Lazo; Francisco A Durazo; Hsin-Chieh Yeh; Myron J Tong; Jeanne M Clark
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

Review 3.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.

Authors:  Jen-Jung Pan; Hui-Qi Qu; Anne Rentfro; Joseph B McCormick; Susan P Fisher-Hoch; Michael B Fallon
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

5.  Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites.

Authors:  Neeta K Venepalli; Mary V Modayil; Stephanie A Berg; Tad D Nair; Mayur Parepally; Priyanka Rajaram; Ron C Gaba; James T Bui; Yue Huang; Scott J Cotler
Journal:  World J Hepatol       Date:  2017-03-08

Review 6.  The Liver in Children With Metabolic Syndrome.

Authors:  Ebe D'Adamo; Valeria Castorani; Valerio Nobili
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

7.  The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.

Authors:  Sana Mansoor; Anshu Maheshwari; Matthew Di Guglielmo; Katryn Furuya; Makala Wang; Erin Crowgey; Zarela Molle-Rios; Zhaoping He
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-09-08

Review 8.  Current concepts and management approaches in nonalcoholic fatty liver disease.

Authors:  Bashar M Attar; David H Van Thiel
Journal:  ScientificWorldJournal       Date:  2013-03-20

Review 9.  Steatosis and steatohepatitis: complex disorders.

Authors:  Kira Bettermann; Tabea Hohensee; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.